*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Syncona Limited is a Guernsey-based closed-ended investment company. The Company is a healthcare company focused on founding, building and funding a portfolio of life science companies. The Companys investment objective is to achieve superior long-term capital appreciation from its investments. The Company invests in life science businesses (including private and quoted companies) and single or multi-asset projects (Life Science Investments).
Registrars:
Key Personnel
Chairman:
Melanie Gee
Non-Executive Director:
Julie Cherrington, Cristina Csimma
Senior Independent Director:
Virginia Holmes
Independent Non-Executive Director:
Robert Hutchinson, Gian Piero Reverberi, Kemal Malik, John Roche
Contact Details
Address:
Frances House , PO Box 273 , Sir William Place , St. Peter Port , Guernsey ,Channel Islands ,United kingdom